ATE108336T1 - Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung. - Google Patents

Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung.

Info

Publication number
ATE108336T1
ATE108336T1 AT88420025T AT88420025T ATE108336T1 AT E108336 T1 ATE108336 T1 AT E108336T1 AT 88420025 T AT88420025 T AT 88420025T AT 88420025 T AT88420025 T AT 88420025T AT E108336 T1 ATE108336 T1 AT E108336T1
Authority
AT
Austria
Prior art keywords
impregnation
solution
inflammatory
sublingual administration
globulins
Prior art date
Application number
AT88420025T
Other languages
English (en)
Inventor
Georges Bruttmann
Patrick Pedrali
Serge Robert
Original Assignee
Medibrevex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibrevex filed Critical Medibrevex
Application granted granted Critical
Publication of ATE108336T1 publication Critical patent/ATE108336T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88420025T 1987-01-28 1988-01-28 Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung. ATE108336T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8701379A FR2609896B1 (fr) 1987-01-28 1987-01-28 Nouvelles formes galeniques de gammaglobulines dites anti-inflammatoires pour administration par voie per- et sub-linguale

Publications (1)

Publication Number Publication Date
ATE108336T1 true ATE108336T1 (de) 1994-07-15

Family

ID=9347597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88420025T ATE108336T1 (de) 1987-01-28 1988-01-28 Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung.

Country Status (6)

Country Link
EP (1) EP0277895B1 (de)
JP (1) JPS63201131A (de)
AT (1) ATE108336T1 (de)
DE (1) DE3850584T2 (de)
ES (1) ES2056119T3 (de)
FR (1) FR2609896B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) * 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460137A1 (fr) * 1979-06-29 1981-01-23 Merieux Inst Nouveau medicament a base d'alpha2-macroglobuline, sa preparation et son application
US4521405A (en) * 1982-05-17 1985-06-04 John McMichael Methods and materials for treatment of disease states involving immunological factors

Also Published As

Publication number Publication date
JPS63201131A (ja) 1988-08-19
DE3850584D1 (de) 1994-08-18
EP0277895A1 (de) 1988-08-10
FR2609896B1 (fr) 1991-06-28
DE3850584T2 (de) 1994-11-10
ES2056119T3 (es) 1994-10-01
EP0277895B1 (de) 1994-07-13
FR2609896A1 (fr) 1988-07-29

Similar Documents

Publication Publication Date Title
NL300277I1 (nl) Galenische vormen van allergenen voor sublinguale toediening.
DE3855323D1 (de) Galenische 2-beta-Mimetik-Formen für die per- und sublinguale Verabreichung
NL930026I2 (nl) Werkwijze voor het bereiden van een frmaceutisch preparaat en werkwijze voor het bereiden vn daarbijtoepasbare gesubstitueerde 1-fenyl-2,3,4,5-tetrah ydro-1H-3-benzapines.
NO177265C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazoler
PT76307B (fr) Procede de preparation de nouveaux derives 3-ceto delta 4,9 19-nor steroides
FI891980A7 (fi) Menetelmä terapeuttisesti aktiivisten N1-(1,2-cis-2-halogeenisyklopropyyli)substituoitujen pyridonikarboksyylihappojohdannaisten valmistamiseksi
NL7605749A (nl) Werkwijze voor de bereiding van 2,6-dimethyl-6- -gesubstitueerde heptaanderivaten.
NL7415433A (nl) Inrichting voor het vervaardigen van uit bouw- elementen bestaande produkten, in het bijzonder personenauto's.
FR2648102B1 (fr) Vehicule non autopropulse, notamment du genre poussette ou analogue
IT1238684B (it) Derivati del bilobalide,loro usi e formulazioni che li contegono
NO801611L (no) Fremgangsmaate for fremstilling av korte legemer av en aluminiumlegering, samt saaledes oppnaadde produkter
ATE108336T1 (de) Galenische formen von antiinflammatorischen gammaglobulinen für die sublinguale verabreichung.
NL7410038A (nl) Werkwijze voor de bereiding van n(6)-digesub- stitueerde adenosinederivaten.
DE3887066D1 (de) Galenische Kortikoidformen für die per- und sublinguale Verabreichung und ihr Herstellungsverfahren.
ATE114245T1 (de) Galenische formen von gammaglobulinen für die sublinguale verabreichung.
NL7704456A (nl) Werkwijze voor de bereiding van farmaceutisch werkzame fenylpiperazinen, werkwijze voor de bereiding van een farmaceutisch preparaat en preparaat, verkregen volgens deze werkwijze.
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI893682L (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
OA04735A (fr) Procédé de préparation de N-arylsulfonyl N'-(aza-3 bicycloalkyl) urées.
FI893121L (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
NL7701695A (nl) Werkwijze voor de bereiding van 2.2-dimethyl- -3-(2'.2'-dichloorvinyl) cyclopropaan-1-carbon- zuur.
NL7600204A (nl) Werkwijze voor de bereiding van 6,11-dihydro-11- -oxydibenz (b,e) oxepinalkaanzuren.
SU698762A1 (ru) Форма дл изготовлени изделий из бетонных смесей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties